Ready-to-Use Formulation of Bivalirudin Injection Now Available
Bivalirudin injection now available in a ready-to-use 250mg/50mL single-use vial.
Stay updated with breaking news from Injectable Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bivalirudin injection now available in a ready-to-use 250mg/50mL single-use vial.
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping bivalirudin injection in a...
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) and Premier, Inc. (NASDAQ: PINC) announced today that Endo's Par Sterile Products business will supply...
DUBLIN, June 29, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Merck's Noxafil® in the U.S., followi...
The first generic version of Noxafil® (posaconazole) injection has been made available by Endo International plc.